This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The PathogenDx SeroX rapid, single test detects Salmonella and 13 serotypes in a single shift to support the food industry’s poultry sector. It includes PathogenDx patented Dynamic Dimensional Detection (D3 array) technology, which is comprised of up to 108 probes—in triplicate, in a single well—to deliver an innovative approach to multiplexed molecular testing. Amplified DNA binding is enabled across a flexible, open 3D cross-linked array architecture, which results in a more flexible, faster, and lower-cost test than qPCR or NGS technology.
SeroX rapidly detects:
- Enteritidis
- Typhimurium
- Newport
- Javiana
- I 4,[5],12:i:- (Monophasic Typhimurium)
- Heidelberg
- Muenchen
- Saintpaul
- Montevideo
- Infantis
- Braenderup
- Oranienberg
- Thompson
“Salmonella outbreaks are a huge issue facing poultry producers, particularly when you look at the astronomical risk and costs associated with an outbreak,” says PathogenDx co-founder and CEO Milan Patel. “For every confirmed case of Salmonella, another 30 go undetected. In fact, the Centers for Disease Control and Prevention estimates that each year one in six Americans—or 48 million people—get sick, 128,000 are hospitalized and 3,000 die of foodborne diseases. To make matters worse, food contaminated with Salmonella usually looks, tastes, and smells normal. That’s why next-gen tests like SeroX are critical to preventing infection and minimizing this threat to public health in the U.S.”
